Author

C. Retiere

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

A. Al-Shamkhani· 1 shared A. F. Vallejo· 1 shared A. Moffett· 1 shared A. Sharkey· 1 shared A. W. E. Purcell· 1 shared B. Mbiribindi· 1 shared F. Colucci· 1 shared H. Ghadially· 1 shared

Activity by Year

2018-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Al-Shamkhani

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Peptide:MHC dependent activation of natural killer cells through KIR2DS2 generates anti-tumor responses

P. Rettman, M. D. Blunt, B. Mbiribindi, R. Fulton, R. Schittenhelm, A. F. Vallejo, L. Bastidas-Legarda, M. E. Polak, R. Ayala, A. W. E. Purcell, A. Al-Shamkhani, C. Retiere, S. I. Khakoo

This study shows that activating NK cells via KIR2DS2 with a peptide:MHC vaccine generates anti-tumor responses and identifies XPO1 as a cancer-associated ligand for KIR2DS2.

bioRxiv · Apr 15, 2020 · PreprintImmunology

High-resolution genetic and phenotypic analysis of KIR2DL1 alleles and their association with pre-eclampsia

O. Huhn, O. Chazara, M. Ivarsson, C. Retiere, T. Venkatesan, H. Ghadially, A. Moffett, A. Sharkey, F. Colucci

The paper develops a method to distinguish KIR2DL1A and KIR2DL1B alleles in NK cells and shows KIR2DL1A is associated with increased pre-eclampsia risk.

bioRxiv · May 25, 2018Immunology